Oct 01, 2021 / 09:00PM GMT
Presentations
Oct 01, 2021 / 09:00PM GMT
=====================
Corporate Participants
=====================
* Kenneth T. Mills
REGENXBIO Inc. - President, CEO & Director
* Patrick J. Christmas
REGENXBIO Inc. - Senior VP & Chief Legal Officer
* Stephen Pakola
REGENXBIO Inc. - Senior VP & Chief Medical Officer
=====================
Conference Call Participants
=====================
* Alec Warren Stranahan
BofA Securities, Research Division - Associate
* Dane Vincent Leone
Raymond James & Associates, Inc., Research Division - Research Analyst
* Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director
* Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
* Luca Issi
RBC Capital Markets, Research Division - Research Analyst
* Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
* Vikram Purohit
Morgan Stanley,
Regenxbio Inc
(NAS:RGNX)
$
10.78
+0.10 (+0.98%)
Market Cap: 711.62 Mil
Enterprise Value: 675.06 Mil
PE Ratio: 0
PB Ratio: 8.14
GF Score: 62/100 Regenxbio Inc KOL Conference Call to Discuss RGX-314 Data Presentations Transcript
Oct 01, 2021 / 09:00PM GMT
Release Date Price:
$40.28
(-3.91%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot